Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy
Authors:
- 7 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 34 (10) , 1780-1788
Abstract
Background: Complement factor H-related protein 5 (CFHR5) nephropathy is an inherited renal disease characterized by microscopic and synpharyngitic macroscopic haematuria, C3 glomerulonephritis and renal failure. It is caused by an internal duplication of exons 2–3 within the CFHR5 gene resulting in dysregulation of the alternative complement pathway. The clinical characteristics and outcomes of transplanted patients with this rare familial nephropathy remain unknown. Methods: This is a retrospective case series study of 17 kidney transplant patients with the established founder mutation, followed-up over a span of 30 years. Results: The mean (±SD) age of patients at the time of the study and at transplantation was 58.6 ± 9.9 and 46.7 ± 8.8 years, respectively. The 10- and 15-year patient survival rates were 100 and 77.8%, respectively. Proteinuria was present in 33.3% and microscopic haematuria in 58.3% of patients with a functional graft. Serum complement levels were normal in all. ‘Confirmed’ and ‘likely’ recurrence of CFHR5 nephropathy were 16.6 and 52.9%, respectively; however, 76.5% of patients had a functional graft after a median of 120 months post-transplantation. Total recurrence was not associated with graft loss (P = 0.171), but was associated with the presence of microscopic haematuria (P = 0.001) and proteinuria (P = 0.018). Graft loss was associated with the presence of proteinuria (P = 0.025). Conclusions: We describe for the first time the clinical characteristics and outcome of patients with CFHR5 nephropathy post-transplantation. Despite the recurrence of CFHR5 nephropathy, we provide evidence for a long-term favourable outcome and support the continued provision of kidney transplantation as a renal replacement option in patients with CFHR5 nephropathy.Keywords
This publication has 45 references indexed in Scilit:
- Complement-Mediated Glomerular Diseases: A Tale of 3 PathwaysKidney International Reports, 2016
- Kidney transplant outcomes in familial C3 glomerulopathyClinical Kidney Journal, 2016
- Pathogenesis of the C3 glomerulopathies and reclassification of MPGNNature Reviews Nephrology, 2012
- C3 Glomerulonephritis/CFHR5 Nephropathy Is an Endemic Disease in Cyprus: Clinical and Molecular Findings in 21 Families2012
- Familial C3 Glomerulopathy Associated with CFHR5 MutationsClinical Journal of the American Society of Nephrology, 2011
- Recurrence of Complement Factor H-Related Protein 5 Nephropathy in a Renal TransplantAmerican Journal of Transplantation, 2011
- Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritisThe Lancet, 2010
- C3 glomerulopathy: a new classificationNature Reviews Nephrology, 2010
- Recurrence of Membranoproliferative Glomerulonephritis Type II in Renal AllograftsJournal of the American Society of Nephrology, 2005
- Recurrence of membranoproliferative glomerulonephritis in renal allograftsTransplantation Proceedings, 1998